Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

$787,601ZIAFY2020AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Ursula Buchholzcontact

Linked publications & trials

Paper 38950078 Paper 38670948 Paper 37352333 Paper 37045860 Paper 35764659

View original record on NIH RePORTER →

Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) · GrantIndex